跳至主要内容
临床试验/JPRN-jRCT1080221926
JPRN-jRCT1080221926未知Unknown

Administration study for Epoetin Beta Pegol product to healthy Japanese adult males

Mitsubishi chemical Medience Corporation0 个研究点目标入组 3 人开始时间: 2012年9月25日最近更新:
适应症

试验速览

阶段
Unknown
发起方
入组人数
3

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 <= 40age old(—)
性别
Male

入选标准

  • Weight: more than 50 kg, BMI :more than 17.6 and below 26.4

排除标准

  • 1. Hypersensitivity to drugs,
  • 2. Polychemia (hemoglobin 16 microgram per dL or more),
  • 3. A history of alcoholism or drug addiction,
  • 4. Ethical or OTC pharmaceuticals administered within two weeks before scheduled administration of the study drug,
  • 5. Supplement, grapefruit or its products, or foods containing Hypericum perforatum consumed within one week before scheduled administration of the study drug,
  • 6. Not less than 200 mL of blood is collected within 30 days or not less than 400 mL of blood is collected within 90 days before scheduled administration of the study drug.

研究者

发起方
Mitsubishi chemical Medience Corporation

相似试验